Postmenopausal Sex hormones in relation to body fat distribution

Obesity

Volumn 20, Issue 5, 2012, Pages 1088-1095

  Liedtke, Stefanie ^a   Schmidt, Martina E ^a   Vrieling, Alina ^a   Lukanova, Annekatrin ^a   Becker, Susen ^a,b   Kaaks, Rudolf ^a   Zaineddin, Aida K ^a   Buck, Katharina ^a   Benner, Axel ^a   Chang Claude, Jenny ^a   Steindorf, Karen ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTRONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ANDROSTENEDIONE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

AGED; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS INDEX; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; ESTRADIOL; ESTROGENS; FEMALE; GERMANY; HUMANS; MIDDLE AGED; OBESITY; POSTMENOPAUSE; QUESTIONNAIRES; SEX HORMONE-BINDING GLOBULIN; TUMOR MARKERS, BIOLOGICAL; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84860297293     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.383     Document Type: Article

References (40)

1. Rinaldi S, Key TJ, Peeters PH et al. Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: A study within the EPIC cohort. Int J Cancer 2006;118:2832-2839.
2. Key TJ, Appleby PN, Reeves GK et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-1226.
3. Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-591.
4. Fortunati N, Catalano MG, Boccuzzi G, Frairia R. Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer. Mol Cell Endocrinol 2010;316:86-92.
5. Hankinson SE, Eliassen AH. Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol 2007;106:24-30.
6. Simpson ER, Merrill JC, Hollub AJ, Graham-Lorence S, Mendelson CR. Regulation of estrogen biosynthesis by human adipose cells. Endocr Rev 1989;10:136-148.
7. Baglietto L, English DR, Hopper JL et al. Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition. Breast Cancer Res Treat 2009;115:171-179.
8. Boyapati SM, Shu XO, Gao YT et al. Correlation of blood sex steroid hormones with body size, body fat distribution, and other known risk factors for breast cancer in post-menopausal Chinese women. Cancer Causes Control 2004;15:305-311.
9. McTiernan A, Wu L, Chen C et al. Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring)2006;14:1662-1677.
10. Mahabir S, Baer DJ, Johnson LL et al. Usefulness of body mass index as a sufficient adiposity measurement for sex hormone concentration associations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006;15:2502-2507.
11. Bezemer ID, Rinaldi S, Dossus L et al. C-peptide, IGF-I, sex-steroid hormones and adiposity: A cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).Cancer Causes Control 2005;16:561-572.
12. Lukanova A, Lundin E, Zeleniuch-Jacquotte A et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: A cross-sectional study in healthy women. Eur J Endocrinol 2004;150:161-171.
13. Madigan MP, Troisi R, Potischman N et al. Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States). Cancer Causes Control 1998;9:199-207.
14. Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 1991;20:151-156.
15. Lamar CA, Dorgan JF, Longcope C et al. Serum sex hormones and breast cancer risk factors in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2003;12:380-383.
16. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:1120-1131.
17. Braunstein GD, Johnson BD, Stanczyk FZ et al. Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. J Clin Endocrinol Metab 2008;93:4268-4275.
18. Allen NE, Appleby PN, Kaaks R et al. Lifestyle determinants of serum insulinlike growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control 2003;14:65-74.
19. Olson MB, Shaw LJ, Kaizar EE et al. Obesity distribution and reproductive hormone levels in women: A report from the NHLBI-sponsored WISE Study. J Womens Health (Larchmt) 2006;15:836-842.
20. Freeman EW, Sammel MD, Lin H, Gracia CR. Obesity and reproductive hormone levels in the transition to menopause. Menopause 2010;17:718-726.
21. Danforth KN, Eliassen AH, Tworoger SS et al. The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women. Int J Cancer 2010;126:199-207.
22. Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ. Circulating levels of sex hormones and their relation to risk factors for breast cancer: A cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 2001;12:47-59.
23. Haffner SM, Katz MS, Dunn JF. Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int J Obes 1991;15:471-478.
24. Pasquali R, Vicennati V, Bertazzo D et al. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group. Metabolism 1997;46:5-9.
25. Flesch-Janys D, Slanger T, Mutschelknauss E et al. Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer 2008;123:933-941.
26. Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J. Reproducibility and relative validity of energy and macronutrient intake of a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26(Suppl 1):S71-S81.
27. Rinaldi S, Geay A, Déchaud H et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 2002;11:1065-1071.
28. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
29. Goodman-Gruen D, Barrett-Connor E. Total but not bioavailable testosterone is a predictor of central adiposity in postmenopausal women. Int J Obes Relat Metab Disord 1995;19:293-298.
30. Hankinson SE, Willett WC, Manson JE et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995;87:1297-1302.
31. Després JP, Nadeau A, Tremblay A et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989;38:304-309.
32. Tchernof A, Lamarche B, Prud'Homme D et al. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 1996;19:629-637.
33. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormonebinding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988;67:460-464.
34. Pouliot MC, Després JP, Lemieux S et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-468.
35. Onat A, Avci GS, Barlan MM et al. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord 2004;28:1018-1025.
36. Hankinson SE, Manson JE, Spiegelman D et al. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995;4:649-654.
37. Micheli A, Muti P, Pisani P et al. Repeated serum and urinary androgen measurements in premenopausal and postmenopausal women. J Clin Epidemiol 1991;44:1055-1061.
38. Muti P, Trevisan M, Micheli A et al. Reliability of serum hormones in premenopausal and postmenopausal women over a oneyear period. Cancer Epidemiol Biomarkers Prev 1996;5:917-922.
39. Prentice AM, Jebb SA. Beyond body mass index. Obes Rev 2001;2:141-147.
40. van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Visser M. Abdominal diameters as indicators of visceral fat: Comparison between magnetic resonance imaging and anthropometry. Br J Nutr 1993;70:47-58.